Molecular imaging of glycogen synthase kinase-3β and casein kinase-1α kinases

Analytical Biochemistry

Volumn 405, Issue 2, 2010, Pages 246-254

  Nyati, Shyam ^a   Ranga, Rajesh ^a   Ross, Brian D ^a   Rehemtulla, Alnawaz ^a   Bhojani, Mahaveer Swaroop ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

CK1 ; GSK3 ; Molecular imaging; Reporter; Split luciferase

Indexed keywords

BIOLUMINESCENCE; CASEIN; CHLORINE COMPOUNDS; ENZYMES; LITHIUM COMPOUNDS; MAMMALS;

CELLULAR PROCESS; FIREFLY LUCIFERASE; GLYCOGEN SYNTHASE KINASE-3; RAPID OPTIMIZATION; REAL TIME MONITORING; REPORTER; SPLIT LUCIFERASE; WESTERN BLOTTING;

MOLECULAR IMAGING;

2 (3 CHLORO 4 HYDROXYANILINO) 3 (2 NITROPHENYL)MALEIMIDE; CASEIN KINASE IALPHA; CKI 7; GLYCOGEN SYNTHASE KINASE 3BETA; LITHIUM CHLORIDE; LUCIFERASE; MUTANT PROTEIN; PHOSPHOTRANSFERASE INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOLUMINESCENCE; CELL STRAIN; CELL STRAIN SW620; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME PHOSPHORYLATION; GENE EXPRESSION; IMMUNOBLOTTING; MALE; MOLECULAR IMAGING; MOUSE; NONHUMAN; PRIORITY JOURNAL; REPORTER GENE; TUMOR XENOGRAFT; VALIDATION PROCESS; WESTERN BLOTTING;

MUS;

EID: 77955564506     PISSN: 00032697     EISSN: 10960309     Source Type: Journal    
DOI: 10.1016/j.ab.2010.06.020     Document Type: Article

References (55)

1. Doble B.W., Woodgett J.R. GSK-3: tricks of the trade for a multi-tasking kinase. J. Cell. Sci. 2003, 116:1175-1186.
2. Grimes C.A., Jope R.S. The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling. Prog. Neurobiol. 2001, 65:391-426.
3. Plyte S.E., Hughes K., Nikolakaki E., Pulverer B.J., Woodgett J.R. Glycogen synthase kinase-3: functions in oncogenesis and development. Biochim. Biophys. Acta 1992, 1114:147-162.
4. Manoukian A.S., Woodgett J.R. Role of glycogen synthase kinase-3 in cancer: regulation by Wnts and other signaling pathways. Adv. Cancer Res. 2002, 84:203-229.
5. Beurel E., Jope R.S. The paradoxical pro- and anti-apoptotic actions of GSK3 in the intrinsic and extrinsic apoptosis signaling pathways. Prog. Neurobiol. 2006, 79:173-189.
6. ter Haar E., Coll J.T., Austen D.A., Hsiao H.M., Swenson L., Jain J. Structure of GSK3beta reveals a primed phosphorylation mechanism. Nat. Struct. Biol. 2001, 8:593-596.
7. Peters J.M., McKay R.M., McKay J.P., Graff J.M. Casein kinase I transduces Wnt signals. Nature 1999, 401:345-350.
8. Zeng X., Tamai K., Doble B., Li S., Huang H., Habas R., Okamura H., Woodgett J., He X. A dual-kinase mechanism for Wnt co-receptor phosphorylation and activation. Nature 2005, 438:873-877.
9. Camacho F., Cilio M., Guo Y., Virshup D.M., Patel K., Khorkova O., Styren S., Morse B., Yao Z., Keesler G.A. Human casein kinase Idelta phosphorylation of human circadian clock proteins period 1 and 2. FEBS Lett. 2001, 489:159-165.
10. Brockman J.L., Gross S.D., Sussman M.R., Anderson R.A. Cell cycle-dependent localization of casein kinase I to mitotic spindles. Proc. Natl. Acad. Sci. USA 1992, 89:9454-9458.
11. Milne D.M., Looby P., Meek D.W. Catalytic activity of protein kinase CK1 delta (casein kinase 1delta) is essential for its normal subcellular localization. Exp. Cell. Res. 2001, 263:43-54.
12. Petronczki M., Matos J., Mori S., Gregan J., Bogdanova A., Schwickart M., Mechtler K., Shirahige K., Zachariae W., Nasmyth K. Monopolar attachment of sister kinetochores at meiosis I requires casein kinase 1. Cell 2006, 126:1049-1064.
13. Behrend L., Milne D.M., Stoter M., Deppert W., Campbell L.E., Meek D.W., Knippschild U. IC261, a specific inhibitor of the protein kinases casein kinase 1-delta, -epsilon, triggers the mitotic checkpoint and induces p53-dependent postmitotic effects. Oncogene 2000, 19:5303-5313.
14. Behrend L., Stoter M., Kurth M., Rutter G., Heukeshoven J., Deppert W., Knippschild U. Interaction of casein kinase 1 delta (CK1delta) with post-Golgi structures microtubules and the spindle apparatus. Eur. J. Cell. Biol. 2000, 79:240-251.
15. Zhu J., Shibasaki F., Price R., Guillemot J.C., Yano T., Dotsch V., Wagner G., Ferrara P., McKeon F. Intramolecular masking of nuclear import signal on NF-AT4 by casein kinase I and MEKK1. Cell 1998, 93:851-861.
16. Papoff G., Trivieri N., Crielesi R., Ruberti F., Marsilio S., Ruberti G. FADD-calmodulin interaction: a novel player in cell cycle regulation. Biochim. Biophys. Acta. 2010, 1803:898-911.
17. Desagher S., Osen-Sand A., Montessuit S., Magnenat E., Vilbois F., Hochmann A., Journot L., Antonsson B., Martinou J.C. Phosphorylation of bid by casein kinases I and II regulates its cleavage by caspase 8. Mol. Cell 2001, 8:601-611.
18. Schwab C., DeMaggio A.J., Ghoshal N., Binder L.I., Kuret J., McGeer P.L. Casein kinase 1 delta is associated with pathological accumulation of tau in several neurodegenerative diseases. Neurobiol. Aging 2000, 21:503-510.
19. Yasojima K., Kuret J., DeMaggio A.J., McGeer E., McGeer P.L. Casein kinase 1 delta mRNA is upregulated in Alzheimer disease brain. Brain Res. 2000, 865:116-120.
20. Xu Y., Padiath Q.S., Shapiro R.E., Jones C.R., Wu S.C., Saigoh N., Saigoh K., Ptacek L.J., Fu Y.H. Functional consequences of a CKIdelta mutation causing familial advanced sleep phase syndrome. Nature 2005, 434:640-644.
21. Mishra S.K., Yang Z., Mazumdar A., Talukder A.H., Larose L., Kumar R., I-gamma2 Metastatic tumor antigen 1 short form (MTA1s) associates with casein kinase an estrogen-responsive kinase. Oncogene 2004, 23:4422-4429.
22. Venerando A., Marin O., Cozza G., Bustos V.H., Sarno S., Pinna L.A. Isoform specific phosphorylation of p53 by protein kinase CK1. Cell Mol. Life Sci. 2010, 67:1105-1118.
23. Korinek V., Barker N., Morin P.J., vanWichen D., deWeger R., Kinzler K.W., Vogelstein B., Clevers H. Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC(-/-) colon carcinoma. Science 1997, 275:1784-1787.
24. Riggleman B., Schedl P., Wieschaus E. spatial expression of the Drosophila segment polarity gene armadillo is posttranscriptionally regulated by wingless. Cell 1990, 63:549-560.
25. Gumbiner B.M. Cell adhesion: the molecular basis of tissue architecture and morphogenesis. Cell 1996, 84:345-357.
26. Polakis P. Wnt signaling and cancer. Genes Dev. 2000, 14:1837-1851.
27. Zhang L., Lee K.C., Bhojani M.S., Khan A.P., Shilman A., Holland E.C., Ross B.D., Rehemtulla A. Molecular imaging of Akt kinase activity. Nat. Med. 2007, 13:1114-1119.
28. Chen X., Liu W., Quinto I., Scala G. High efficiency of site-directed mutagenesis mediated by a single PCR product. Nucleic Acids Res. 1997, 25:682-684.
29. Abramoff M.D., Magalhaes P.J., Ram S.J. Image processing with ImageJ. Biophotonics Int. 2004, 11:36-42.
30. Liu C., Li Y., Semenov M., Han C., Baeg G.H., Tan Y., Zhang Z., Lin X., He X. Control of beta-catenin phosphorylation/degradation by a dual-kinase mechanism. Cell 2002, 108:837-847.
31. Durocher D., Jackson S.P. The FHA domain. FEBS Lett. 2002, 513:58-66.
32. Luker K.E., Smith M.C., Luker G.D., Gammon S.T., Piwnica-Worms H., Piwnica-Worms D. Kinetics of regulated protein-protein interactions revealed with firefly luciferase complementation imaging in cells and living animals. Proc. Natl. Acad. Sci. USA 2004, 101:12288-12293.
33. Coghlan M.P., Culbert A.A., Cross D.A., Corcoran S.L., Yates J.W., Pearce N.J., Rausch O.L., Murphy G.J., Carter P.S., Roxbee Cox L., Mills D., Brown M.J., Haigh D., Ward R.W., Smith D.G., Murray K.J., Reith A.D., Holder J.C. Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription. Chem. Biol. 2000, 7:793-803.
34. MacAulay K., Hajduch E., Blair A.S., Coghlan M.P., Smith S.A., Hundal H.S. Use of lithium and SB-415286 to explore the role of glycogen synthase kinase-3 in the regulation of glucose transport and glycogen synthase. Eur. J. Biochem. 2003, 270:3829-3838.
35. Kao K.R., Masui Y., Elinson R.P. Lithium-induced respecification of pattern in Xenopus laevis embryos. Nature 1986, 322:371-373.
36. Clement-Lacroix P., Ai M., Morvan F., Roman-Roman S., Vayssiere B., Belleville C., Estrera K., Warman M.L., Baron R., Rawadi G. Lrp5-independent activation of Wnt signaling by lithium chloride increases bone formation and bone mass in mice. Proc. Natl. Acad. Sci. USA 2005, 102:17406-17411.
37. Morin P.J., Sparks A.B., Korinek V., Barker N., Clevers H., Vogelstein B., Kinzler K.W. Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science 1997, 275:1787-1790.
38. Willert K., Brown J.D., Danenberg E., Duncan A.W., Weissman I.L., Reya T., Yates J.R., Nusse R. Wnt proteins are lipid modified and can act as stem cell growth factors. Nature 2003, 423:448-452.
39. Spink K.E., Polakis P., Weis W.I. Structural basis of the Axin-adenomatous polyposis coli interaction. Embo J. 2000, 19:2270-2279.
40. Hart M.J., de los Santos R., Albert I.N., Rubinfeld B., Polakis P. Downregulation of beta-catenin by human axin its association with the APC tumor suppressor beta-catenin and GSK3 beta. Curr. Biol. 1998, 8:573-581.
41. Kunnimalaiyaan M., Vaccaro A.M., Ndiaye M.A., Chen H. Inactivation of glycogen synthase kinase-3 beta a downstream target of the raf-1 pathway is associated with growth suppression in medullary thyroid cancer cells. Mol. Cancer Ther. 2007, 6:1151-1158.
42. Amit S., Hatzubai A., Birman Y., Andersen J.S., Ben-Shushan E., Mann M., Ben-Neriah Y., Alkalay I. Axin-mediated CKI phosphorylation of beta-catenin at Ser 45: a molecular switch for the Wnt pathway. Genes Dev. 2002, 16:1066-1076.
43. Yanagawa S., Matsuda Y., Lee J.S., Matsubayashi H., Sese S., Kadowaki T., Ishimoto A. Casein kinase I phosphorylates the Armadillo protein and induces its degradation in Drosophila. Embo J. 2002, 21:1733-1742.
44. Matsubayashi H., Sese S., Lee J.S., Shirakawa T., Iwatsubo T., Tomita T., Yanagawa S. Biochemical characterization of the Drosophila wingless signaling pathway based on RNA interference. Mol. Cell. Biol. 2004, 24:2012-2024.
45. Polakis P. Casein kinase 1: a Wnt'er of disconnect. Curr. Biol. 2002, 12:R499-R501.
46. van Es J.H., Barker N., Clevers H. You Wnt some, you lose some: oncogenes in the Wnt signaling pathway. Curr. Opin. Genet. Dev. 2003, 13:28-33.
47. Hagen T., Vidal-Puig A. Characterisation of the phosphorylation of beta-catenin at the GSK-3 priming site Ser45. Biochem. Biophys. Res Commun. 2002, 294:324-328.
48. Wang Z., Vogelstein B., Kinzler K.W. Phosphorylation of beta-catenin at S33 S37 or T41 can occur in the absence of phosphorylation at T45 in colon cancer cells. Cancer Res. 2003, 63:5234-5235.
49. Beaulieu J.M., Sotnikova T.D., Yao W.D., Kockeritz L., Woodgett J.R., Gainetdinov R.R., Caron M.G. Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade. Proc. Natl. Acad. Sci. USA 2004, 101:5099-5104.
50. Wood A.J., Goodwin G.M., De Souza R., Green A.R. The pharmacokinetic profile of lithium in rat and mouse; an important factor in psychopharmacological investigation of the drug. Neuropharmacology 1986, 25:1285-1288.
51. Hirota T., Lewis W.G., Liu A.C., Lee J.W., Schultz P.G., Kay S.A. A chemical biology approach reveals period shortening of the mammalian circadian clock by specific inhibition of GSK-3 beta. Proc. Natl. Acad. Sci. USA 2008, 105:20746-20751.
52. Iitaka C., Miyazaki K., Akaike T., Ishida N. A role for glycogen synthase kinase-3 beta in the mammalian circadian clock. J. Biol. Chem. 2005, 280:29397-29402.
53. Harada Y., Sakai M., Kurabayashi N., Hirota T., Fukada Y. Ser-557-phosphorylated mCRY2 is degraded upon synergistic phosphorylation by glycogen synthase kinase-3 beta. J. Biol. Chem. 2005, 280:31714-31721.
54. Kannoji A., Phukan S., Sudher Babu V., Balaji V.N. GSK3beta: a master switch and a promising target. Expert Opin. Ther. Targets 2008, 12:1443-1455.
55. Rayasam G.V., Tulasi V.K., Sodhi R., Davis J.A., Ray A. Glycogen synthase kinase 3: more than a namesake. Brit. J. Pharmacol. 2009, 156:885-898.